RiverFront Investment Group »

Mirum Pharmaceuticals shares owned by RiverFront Investment Group

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by RiverFront Investment Group from 13F filings

Historical chart of RiverFront Investment Group investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by RiverFront Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by RiverFront Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.4M 12k 117.07

More positions owned by RiverFront Investment Group

Ishares Tr Core Msci Common (IEFA)
Vaneck Etf Trust Semi Common (SMH)
Goldman Sachs Etf Tr Common (GSLC)
Ishares Tr U.s. Tech Common (IYW)
Apple Common (AAPL)
Select Sector Spdr Tr Common (XLK)
Ishares Tr Eafe Value Common (EFV)
Nvidia Corporation Common (NVDA)
J P Morgan Exchange T Common (JIVE)
Spdr Series Trust Por Common (SPAB)
J P Morgan Exchange T Etf - E (JEPI)
Schwab Strategic Tr 5 Common (SCHI)
Vanguard Bd Index Common (BND)
Invesco Qqq Tr Unit S Common (QQQ)
Spdr Series Trust Por Common (SPYM)

View all positions for RiverFront Investment Group

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
Henderson Group
Jupiter Topco
BlackRock
FMR
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
T. Rowe Price Associates
William Blair Investment Management
Geode Capital Management
Invesco
Wellington Management Company
Eventide Asset Management
Tang Capital Management

View all funds holding Mirum Pharmaceuticals